Lighthouse Pharmaceuticals Announces Presentation at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Lighthouse to present new LHP588 clinical data and SPRING Trial study design SAN FRANCISCO, May 24, 2023 /PRNewswire/ -- Lighthouse Pharmaceuticals, a clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer's and other degenerative diseases,...

Click to view original post